
$2.4M Fast Track Grant Awarded for PSMA-Targeted Prostate Cancer Drug
Cancer Targeted Technology (CTT), a Seattle-based biotechnology company focused on cancer diagnostics and therapies, announced that the National Cancer Institute has awarded the Phase I portion ($400K) of a fast-track…












